Donald L. Hagan LLC’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-169,514
Closed -$150K 123
2022
Q4
$150K Buy
169,514
+20,037
+13% +$26.6K 0.09% 85
2022
Q3
$235K Buy
149,477
+60,739
+68% +$138K 0.17% 82
2022
Q2
$178K Buy
88,738
+1,804
+2% +$3.12K 0.11% 91
2022
Q1
$203K Buy
86,934
+13,350
+18% +$41.6K 0.11% 92
2021
Q4
$342K Buy
73,584
+30,655
+71% +$190K 0.18% 88
2021
Q3
$328K Buy
42,929
+2,871
+7% +$24.3K 0.19% 85
2021
Q2
$388K Buy
40,058
+3,935
+11% +$31.3K 0.23% 79
2021
Q1
$299K Buy
36,123
+11,697
+48% +$124K 0.2% 81
2020
Q4
$167K Buy
24,426
+8,724
+56% +$70.1K 0.12% 83
2020
Q3
$175K Buy
15,702
+3,600
+30% +$32.9K 0.14% 78
2020
Q2
$76K Sell
12,102
-13,900
-53% -$53.2K 0.07% 81
2020
Q1
$67K Buy
26,002
+4,902
+23% +$14.1K 0.06% 79
2019
Q4
$89K Buy
+21,100
New +$50.3K 0.08% 86

Other funds holding SRNE